Welcome to Sequence Card of Peptide


Details of CancerPDF entry with Sequence VTEPISAESGEQVERVNEPSILEMS
Primary information
sequence IDSeq_9379
Peptide sequenceVTEPISAESGEQVERVNEPSILEMS
CancerPDF_ID CancerPDF_ID833, CancerPDF_ID1988, CancerPDF_ID1990, CancerPDF_ID3243,
PMID19795908,21136997,21136997,21136997
Protein NameApolipoprotein L1,Apolipoprotein-L1,Apolipoprotein-L1,Apolipoprotein-L1
UniprotKB Entry NameAPOL1_HUMAN,APOL1_HUMAN,APOL1_HUMAN,APOL1_HUMAN
FluidPlasma,Serum,Serum,Plasma
M/Z910.77,2729.30655,2745.30147,2729.3065
Charge3,1,1,1
Mass (in Da)NA,NA,NA,NA
fdrNA,NA,NA,NA
Profiling TechniqueLC-MS,LC-MS,LC-MS,LC-MS
Peptide Identification techniqueMALDI-TOF/TOF,LC-MS-MS/MS,LC-MS-MS/MS,LC-MS-MS/MS
Quantification TechniqueLC-MRM (multiple reaction monitoring),LC-ESI-MS,LC-ESI-MS,LC-ESI-MS
Labelled/Label FreeLabelled,Label Free,Label Free,Label Free
FDRless than 7%,NA,NA,NA
CancerPDF_ID CancerPDF_ID833, CancerPDF_ID1988, CancerPDF_ID1990, CancerPDF_ID3243,
p-ValueNA,NA,NA,NA
SoftwareFlexAnalysis 3.0 and Biotools 3.0 software,MASCOT(v. 2.2.01),MASCOT(v. 2.2.01),MASCOT(v. 2.2.01)
Length25,25,25,25
Cancer TypeDuctal adenocarcinoma of the pancreas (DAP),Colorectal cancer,Colorectal cancer,Normal
DatabaseNCBI refseq Protein Database,SwissProt Database,SwissProt Database,SwissProt Database
ModificationNA,NA,Oxidation of Met,NA
Number of Patients"40 normal, 23 patients",30 patients and 30 healthy controls,30 patients and 30 healthy controls,27 healthy individuals
RegulationNA,NA,NA,NA
ValidationNA,Leave One out Cross validation,Leave One out Cross validation,Leave One out Cross validation
SensitivityNA,NA,NA,NA
SpecificityNA,NA,NA,NA
AccuracyNA,NA,NA,NA
Peptide AtlasNA
IEDB